Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient
Open accessAbstract
BACKGROUND: Nearly 1% of the population is currently treated with long-term corticosteroid therapy. When corticosteroids are introduced, information concerning potential adverse effects and recommendations for lifestyle changes aimed at preventing such effects is provided to patients. However, studies have shown patients often do not fully comprehend the information provided and have difficulty implementing the recommended dietary and physical activity advice. In this study, we aim to highlight the difficulties encountered by patients in comprehending and implementing recommendations in the context of long-term corticosteroid use. Such information can be used to better optimize care, particularly concerning adherence to the treatment, the diet, and thus improve the quality of life of patients. METHODS: We recruited adult patients under long-term corticosteroid (≥ 3 months, ≥ 5 mg/day) treatment from both general medicine and rheumatology practices. We performed a qualitative analysis based on semi-structured interviews of these patients. Transcripts of these interviews were then compiled and analysed using a thematic approach. RESULTS: Sixteen patients were included. Analysis of the interviews revealed that patients' hope for effective corticosteroid treatment was counterbalanced by concerns over potential adverse effects. In some patients, the need to respect a strict and imposed diet induced psychological distress, potentially leading to eating disorders or fear of social exclusion. Furthermore, patient ambivalence toward the therapeutic education was highlighted, as well as the notion of filtering information, conscious or unconscious, as revealed by their lack of recall. The relationship with the physician also affected the treatment experience. CONCLUSION: Our analysis of the personal experience of patients regarding recommended lifestyle changes associated with long-term corticosteroid treatment highlights patient difficulties and suggests different ways of improving therapeutic education.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Salt reduction is not indicated as primary prevention of arterial hypertension in patients with corticosteroid therapy.
“The salt reduction is not”
From ESPEN guideline on hospital nutrition (2021) · cites this paper as [165]
The Background (page unavailable) says salt reduction is among the dietary advice given to patients on corticosteroids, but that there are no official recommendations and evidence of efficacy is lacking. The Discussion (page unavailable) likewise says the effectiveness of strict low-salt advice has not been scientifically proven. Neither passage establishes the stronger claim that salt reduction is not indicated specifically for primary prevention of arterial hypertension. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383 · see citing works
Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years
Fardet, L., Petersen, I., & Nazareth, I. (2011) · Rheumatology · doi:10.1093/rheumatology/ker017 · Cited by 319 · see citing works
Flagged first, then by citations
Research works printed but not linked: 26
- [1]Briot K Cortet B Roux C Fardet L Abitbol V Bacchetta J 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis Joint Bone Spine 2014 81 6 493 501 10.1016/j.jbspin.2014.10.001 25455041 · DOI
- [3]Overman RA Yeh J-Y Deal CL Prevalence of oral glucocorticoid usage in the United States: a general population perspective Arthritis Care Res 2013 65 2 294 298 10.1002/acr.21796 22807233 · DOI · Paper page
- [4]Van Staa TP Leufkens HG Abenhaim L Begaud B Zhang B Cooper C Use of oral corticosteroids in the United Kingdom QJM Mon J Assoc Physicians 2000 93 2 105 111 10.1093/qjmed/93.2.105 10700481 · DOI · Paper page
- [6]Perdoncini-Roux A Blanchon T Hanslik T Lasserre A Turbelin C Dorleans Y Description of French general practitioners’ practices regarding long term systemic corticosteroid therapy-associated measures Rev Prat 2009 59 8 Suppl 19 24 19916281
- [8]Fardet L Kettaneh A Gérol J Tolédano C Tiev K-P Cabane J Effet à court terme des apports sodés sur la pression artérielle des patients recevant une corticothérapie systémique: étude prospective, randomisée, croisée Rev Méd Interne 2009 30 9 741 746 10.1016/j.revmed.2009.03.009 19361897 · DOI · Paper page
- [9]Sailler L Pugnet G Arlet P Corticothérapie systémique: les mesures d’accompagnement Rev Méd Interne 2013 34 5 279 283 10.1016/j.revmed.2012.12.003 23312495 · DOI · Paper page
- [11]Fardet L Hanslik T Blanchon T Perdoncini-Roux A Kettaneh A Tiev KP Mesures adjuvantes à une corticothérapie systémique prolongée: description des pratiques des médecins internistes français Rev Méd Interne 2008 29 12 975 980 10.1016/j.revmed.2008.04.001 18501996 · DOI
- [12]Lamchahab FE Reffas W Bouattar T Abdellaoui EK Ouzeddoun N Bayahia R Mesures adjuvantes à une corticothérapie systémique prolongée: que faut-il prescrire ? Ann Pharm Fr 2012 70 5 292 297 10.1016/j.pharma.2012.07.007 23020920 · DOI
- [13]Zerah L Arena C Morin A-S Blanchon T Cabane J Fardet L Le ressenti des patients vis-à-vis d’une corticothérapie orale prolongée influence l’adhérence déclarée à ce traitement Rev Méd Interne 2012 33 6 300 304 10.1016/j.revmed.2012.02.001 22444116 · DOI
- [14]Arena C Morin A-S Blanchon T Hanslik T Cabane J Dupuy A Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy: adverse events and adherence to glucocorticoids Br J Dermatol 2010 163 4 832 837 10.1111/j.1365-2133.2010.09877.x 20518780 · DOI
- [15]Nassar K Janani S Roux C Rachidi W Etaouil N Mkinsi O La corticothérapie systémique au long cours: représentations des patients, perceptions des prescripteurs et observance thérapeutique Rev Rhum 2014 81 1 49 53 10.1016/j.rhum.2013.04.008 · DOI
- [16]Gil H Méaux-Ruault N Magy-Bertrand N Hafsaoui C Dupond J-L Corticothérapie prolongée: impact sur la qualité de vie des patients.« la cortisone⋯est-ce vraiment l’enfer? ». Rev Méd Interne 2006 27 S323 S324 10.1016/j.revmed.2006.10.089 · DOI
- [17]Fardet L Flahault A Kettaneh A Tiev KP Généreau T Tolédano C Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?S opinion Br J Dermatol 2007 157 1 142 148 10.1111/j.1365-2133.2007.07950.x 17501951 · DOI
- [18]Fardet L Blanchon T Perdoncini-Roux A Kettaneh A Tiev K Turbelin C Perception par les médecins internistes de la fréquence et de la gêne induite par les effets indésirables d’une corticothérapie systémique prolongée Rev Méd Interne 2009 30 2 113 118 10.1016/j.revmed.2008.08.004 18819732 · DOI
- [19]Perdoncini-Roux A Blanchon T Hanslik T Lasserre A Turbelin C Dorleans Y Perception par les médecins généralistes de la gêne induite par les effets indésirables d’une corticothérapie systémique prolongée Rev DÉpidémiologie Santé Publique 2009 57 2 93 97 10.1016/j.respe.2008.12.009 19303232 · DOI
- [20]Riviere S Konate A Ceballos P Crozat S Le quellec A Tolérance de la corticothérapie: Prise en charge diététique et suivi du régime. Résultats préliminaires Rev Méd Interne 2002 23 73 10.1016/S0248-8663(02)80157-6 · DOI
- [21]Fardet L Flahault A Kettaneh A Tiev K-P Tolédano C Lebbe C Corticothérapie systémique et alimentation: suivi des recommandations diététiques et relation entre apports alimentaires et apparition d’une lipodystrophie Rev Méd Interne 2007 28 5 284 288 10.1016/j.revmed.2006.12.013 17391811 · DOI
- [23]Simon A Ané A-M Afroun A Corticoïdes et éducation thérapeutique: expérience d’un service de médecine interne Rev Méd Interne 2013 34 5 287 292 10.1016/j.revmed.2012.12.010 23332660 · DOI
- [24]Horne R Weinman J Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness J Psychosom Res 1999 47 6 555 567 10.1016/S0022-3999(99)00057-4 10661603 · DOI · Paper page
- [25]Menckeberg TT Bouvy ML Bracke M Kaptein AA Leufkens HG Raaijmakers JAM Beliefs about medicines predict refill adherence to inhaled corticosteroids J Psychosom Res 2008 64 1 47 54 10.1016/j.jpsychores.2007.07.016 18157999 · DOI
- [27]Turato ER Qualitative and quantitative methods in health: definitions, differences and research subjects Rev Saude Publica 2005 39 3 507 514 10.1590/S0034-89102005000300025 15997330 · DOI
- [29]Hummers-Pradier E Scheidt-Nave C Martin H Heinemann S Himmel W Simply no time? Barriers to GPs’ participation in primary health care research Fam Pract 2008 225 2 105 112 10.1093/fampra/cmn015 18417465 · DOI
- [30]Vietch C Hollins J Worley P Mitchell G General practice research. Problems and solutions in participant recruitment and retention Aust Fam Physician 2001 30 4 399 406 11355233
- [31]Coppa K Boyle F The role of self-help groups in chronic illness management: a qualitative study Aust J Prim Health 2003 9 3 68 74 10.1071/PY03026 · DOI
- [34]Poisson J Six M Morin C Fardet L Corticoïdes et corticothérapies: quelle est l’information recherchée par les patients ? Analyse des visites du site Internet cortisone-info.fr Rev Méd Interne 2013 34 5 255 257 10.1016/j.revmed.2013.02.015 23537896 · DOI
- [35]Duru N van der Goes MC Jacobs JWG Andrews T Boers M Buttgereit F EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases Ann Rheum Dis 2013 72 12 1905 1913 10.1136/annrheumdis-2013-203249 23873876 · DOI
Cited by
Sorted by citations
ESPEN guideline on hospital nutrition
Thibault, R., Abbasoglu, O., Ioannou, E., Meija, L., Ottens-Oussoren, K., Pichard, C., Rothenberg, E., Rubin, D., Siljamäki-Ojansuu, U., Vaillant, M.-F., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.039 · Cited by 259 · see citing works
- Authors
- Nogué, M., Rambaud, J., Fabre, S., Filippi, N., Jorgensen, C., & Pers, Y.-M.
- Affiliations
- Centre Hospitalier Universitaire de Montpellier (FR)
- Université de Montpellier (FR)
- Corresponding author
- Nogué, Muriel
- ORCID
- Pers, Yves-Marie
- Venue
- BMC Health Services Research
- Published
- 2019-04-26
- Volume
- 19
- Issue
- 1
- Pages
- 255-255
- ISSN
- 1472-6963 (ISSN-L)
- PMC
- PMC6486686
- OpenAlex
- W2940630884
- Cited by
- 19
- References
- 2
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Health Services Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- long-term corticosteroid therapy, dietary recommendations, lifestyle modification, patient understanding, medication adherence, corticosteroid adverse effects, psychological distress, eating disorders, social exclusion, therapeutic education, physician-patient relationship, rheumatology patients, patient experience
- MeSH terms
- Healthy Lifestyle, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Counseling, Diet, Female, Humans, Long-Term Care, Male, Middle Aged, Patient Education as Topic, Physician-Patient Relations, Quality of Life, Exercise, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review